Delaware
(State
or Other Jurisdiction of Incorporation)
|
0-22179
(Commission
File Number)
|
58-2029543
(IRS
Employer Identification No.)
|
5835
Peachtree Corners East, Suite D
Norcross,
Georgia
(Address
of Principal Executive Offices)
|
30092
(Zip
Code)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
For
|
Withheld/
Against
|
Abstain
|
Broker
Non-Votes*
|
|
Common
stock and series A convertible preferred stock, voting together as a
single class
|
16,509,432
|
267,131
|
50,267
|
0
|
Series
A convertible preferred stock voting separately as a class
|
7,226,896
|
0
|
0
|
0
|
Exhibit No. | Description | |
99.1 | Text of Amendment to Certificate of Incorporation |
GUIDED THERAPEUTICS, INC | |||
By: | /s/ MARK L. FAUPEL | ||
Mark L. Faupel, Ph.D. | |||
CEO & President | |||
Date: February 26, 2010 |